1-4 of 4
Dalena Chu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD6 Is a Modulator of Treg Differentiation and Activity

Jeanette Ampudia, Dalena Chu, Stephen Connelly, Cherie Ng
Journal: Blood
Blood (2022) 140 (Supplement 1): 12653–12654.
https://doi.org/10.1182/blood-2022-170268
Published: 2022
Journal Articles

Antigenic Modulation of CD6 By Itolizumab Is a New Mechanism for Effector T Cell Inhibition

Dalena Chu, Valeria Marrocco, Phoi Tiet, Jeanette Ampudia, Stephen Connelly, Cherie Ng
Journal: Blood
Blood (2021) 138 (Supplement 1): 995.
https://doi.org/10.1182/blood-2021-148805
Published: 2021
Journal Articles

Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Combination with Corticosteroids, Is Well-Tolerated, with Rapid Pharmacodynamic and Clinical Response in Newly Diagnosed Acute Graft-Versus-Host Disease

John Koreth, Jerome Ritz, Leslie Chinn, Cherie Ng, Lisette M Acevedo, Dalena Chu, Maple Fung, Joel Rothman, Stephen Connelly, Dolca Thomas, Corey Cutler
Journal: Blood
Blood (2021) 138 (Supplement 1): 2891.
https://doi.org/10.1182/blood-2021-145721
Published: 2021
Journal Articles

Impact of Itolizumab on the Expression of CD6 and the Function of Effector T Cells

Jeanette Ampudia, Dalena Chu, MS, Jana Badrani, MS, Taylor Doherty, MD, Stephen Connelly, PhD MBA, Cherie Tracy Ng, PhD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-141638
Published: 2020